Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease

Management of hyperphosphatemia in patients with dialysis-dependent chronic kidney disease remains a major challenge, requiring a multifaceted approach that includes dietary phosphate restriction, dialysis, and phosphate binders. However, these treatments fail to meet serum phosphate targets in many...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouque, Denis, Vervloet, Marc, Ketteler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132443/
https://www.ncbi.nlm.nih.gov/pubmed/30022383
http://dx.doi.org/10.1007/s40265-018-0950-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132443/
https://www.ncbi.nlm.nih.gov/pubmed/30022383
http://dx.doi.org/10.1007/s40265-018-0950-2

Ejemplares similares